Last reviewed · How we verify
NCT04904887
Clinical Outcomes With a New Monofocal IOL Enhanced for Intermediate Vision
NA trial testing phacoemulsification in Presbyopia in 40 participants. Status unknown.
30 July 2021
Quick facts
| Lead sponsor | Dar Al Shifa Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 November 2020 |
| Primary completion | 30 July 2021 |
| Estimated completion | 30 October 2021 |
| Sites | 1 location across Kuwait |
Drugs / interventions tested
- phacoemulsification
Conditions studied
- Presbyopia — all drugs for Presbyopia →
Sponsor
Dar Al Shifa Hospital
Who can join
40 and older, any sex, with Presbyopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
phacoemulsification with insertion of EYHANCE IOL to improve near and intermediate vision
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04904887
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of phacoemulsification
Trials testing the same drug.
- NCT06904560 — The Relation Between BSS Solution Temperature and Endothelial Cells and Post Phaco Discomfort · NA · not yet recruiting
- NCT07252154 — Modified Nuclear Phacoemulsification in Brown Cataract · NA · completed
- NCT06974578 — Capsular Tension Ring With Hydeophilic Intraocular Lesnes to Decrease Posterior Capsule Opacification Versus Hydrophobic · NA · completed
- NCT05871034 — Electroretinogram and Retinal Vascular Changes After Cataract Surgery · NA · unknown
- NCT06741774 — Efficacy and Safety of Trabecular Meshwork Microstent Drainage System ( MicroCOGO ) · NA · active not recruiting
Other recruiting trials for Presbyopia
Currently open trials in the same condition.
- NCT07444658 — Performance of Two Daily Disposable Multifocal Contact Lenses · NA · recruiting
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07077967 — Luminous Efficiency Function V(λ)' of Patients That Underwent Pseudophakic Presbyopic Corrections With EDOF IOLs · recruiting
- NCT07113210 — Quality of Life in Presbyopic Patients Who Are Treated With Qlosi · Phase 4 · recruiting
- NCT06948357 — Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients · Phase 2 · recruiting
Other Dar Al Shifa Hospital trials
Trials by the same sponsor.
- NCT04904874 — Intense Pulsed Light Therapy in Meibomian Gland Dysfunction · NA · unknown
- NCT04907955 — Visual Performance Following Implantation of Presbyopia Correcting IOLs · NA · completed
- NCT03288116 — Objective and Subjective Diagnostic Parameters in the Fellow Eye of Unilateral Keratoconus · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04904887 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dar Al Shifa Hospital
- Last refreshed: 27 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04904887.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing